Pharmnet
English
News
Pharmnet submitted for approval 25th pediatric trial

Pharmnet submitted for approval 25th pediatric trial

(9. 5. 2017)

Pharmnet continues successfuly in delivering the reliable results within the expected timelines while stays successfully adherent to the timelines passing all challenges specific for pediatric trials.

From the unique experience over the past two decades based on over 260 clinical trials across various therapeutic areas, 25 trials were and are running in pediatric population. Our success is based on the understanding of the specific needs of the trials with the vulnerable population. Increasing cumulative experience is based on the number of projects ran year by year over the company history (graph shows the number of active trials within the corresponding years):

 

Back
Across Alliance
Season's Greetings and Happy New Year!Pharmnet's youngest generation seems to have a fairly clear vision of the future.pic.twitter.com/5QOt6f4BoB
LinkedIn
Pharmnet © 2022